The percentage of CD11b and CD14 positive were both increased after Baicalein treatment for 96 h in U937, THP‐1, Kasumi‐1, SKNO‐1 cells, and primary AML cells (Table 2; Figure 2C‐E). The gene discussed is CD14; the disease is acute myeloid leukemia.